baber/WOPTO huggingface dataset:
Patent AT-E183109-T1 (AT)
Inventor: KOSTANIAN ARTAK ERANOSOVICH
IPC: B01D11/04
Filed: 1996-10-11
Granted: 1999-08-15
Abstract: PCT No. PCT/EP96/04424 Sec. 371 Date Mar. 26, 1998 Sec. 102(e) Date Mar. 26, 1998 PCT Filed Oct. 11, 1996 PCT Pub. No. WO97/14488 PCT Pub. Date Apr. 24, 1997The multistage three-phase extractor is provided with ports 7, 8 for the supply and ports 10, 11 for the removal of first and second dispersed phases and has contact stages 3 arranged one below the other, which each comprise two interconnected chambers 1, 2 filled with the continuous phase, wherein the first stage is equipped with a dispersing device 5. The first chamber 1 of an upper stage is connected with the second chamber 2 of the stage therebelow. The continuous phase is supplied to the first stage via the port 11 and removed from the last stage via the port 12.
Patent AT-E185219-T1 (AT)
Inventor: TETIK ADOLF
IPC: H01H71/24
Filed: 1996-12-18
Granted: 1999-10-15
Abstract: The invention relates to an armature (10) for magnetic trigger mechanisms (1) for safety switches, in particular for automatic cut-out switches, which comprises a sheet-metal strip which is formed to produce a sleeve of circular-ring cross-section. The ends (20) of said strip are aligned in relation to the armature (10) axis and lie close to each other at least in places. The stop for driving the tripping tappet(14) is a tongue (12) which along with the sheet-metal strip forms one member and is aligned transversely to the axis of the armature (10). To keep the air gap in the joint region (21) of the sleeve as small as possible, the edges (20) in the joint region (21) of the armature (10) can rest flatly against each other.
Patent AT-E252494-T1 (AT)
Inventor: ROENLEV ERIK
IPC: B65D41/04
Filed: 1996-11-28
Granted: 2003-11-15
Abstract: The present invention relates to a container for pills comprising a container part (1) and a lid (8, 9) where closure is effected by screwing on the lid (8, 9). To facilitate screwing the lid off and on for persons with reduced fine motor function, according to the invention the threads (3, 4, 5, 10, 11, 12) are designed with a small angle of wrap corresponding to 270 DEG  +/- 45 DEG , and to ensure sealing despite the short thread length, the outer edge (27) of the container part (1) is arranged to be in contact with the lid (8, 9) along three circular sealing lines (A, B, C).
Patent AT-E296522-T1 (AT)
Inventor: KRUEGER UWE DIPL-ING
IPC: H04Q3/62
Filed: 1997-03-11
Granted: 2005-06-15
Abstract: Selection information is evaluated when connections are formed in a communication system. According to the result of the evaluation, the selection information is used to form a communication connection in a second communication network (e.g. ISDN). If the evaluation result is different, an additional selection is used to form a connection between the second communication network and the first communication network (Corporate Network). The selection information is used to send a signal indicating a connection in a sub-selection information field to the first communication network.
Patent AT-E231131-T1 (AT)
Inventor: HANSEN THOMAS KRUSE
IPC: C07D243/08
Filed: 1997-04-24
Granted: 2003-02-15
Abstract: The present invention relates to novel compounds of general formula (I) which can be used for treating medical disorders resulting from a deficiency in growth hormone.
Patent AT-E368103-T1 (AT)
Inventor: JOHE KARL
IPC: A61K35/12
Filed: 1997-05-07
Granted: 2007-08-15
Abstract: The present invention reveals in vitro cultures of region-specific, terminally differentiated, mature neurons derived from cultures of mammalian multipotential CNS stem cells and an in vitro procedure by which the differentiated neurons may be generated. The procedure involves the culturing of multipotential CNS stem cells from a specific region in a chemically defined serum-free culture medium containing a growth factor; replacing the medium with growth factor-free medium; harvesting the stem cells by trypsinization; plating the stem cells at a density of between 100,000 to 250,000 cells per square centimeter; and culturing the stem cells in a glutamic acid-free chemically defined serum-free culture medium.
Patent AT-E281705-T1 (AT)
Inventor: MIRANDA GIOVANNI
IPC: H02G3/04
Filed: 1997-06-13
Granted: 2004-11-15
Abstract: PCT No. PCT/DE97/01245 Sec. 371 Date Jul. 23, 1998 Sec. 102(e) Date Jul. 23, 1998 PCT Filed Jun. 13, 1997 PCT Pub. No. WO97/50161 PCT Pub. Date Dec. 31, 1997A cable channel section including a plurality of wall elements pivotable in a predetermined angular region, hinge elements for releasably connecting adjacent wall elements with a possibility of a pivotal movement of one of the adjacent wall elements relative to another of the adjacent wall elements and formed integrally with respective adjacent wall elements, and locking elements for fixedly securing the adjacent wall elements in their end position with one locking element being formed as a detent hook carried by a stationary leg projecting from one of the adjacent wall elements, and another locking element being formed as a locking heel carried by an elastically deflectable resilient finger formed integrally with another of the adjacent wall elements.
Patent AT-E249222-T1 (AT)
Inventor: GAST MICHAEL JAY
IPC: A61K31/57
Filed: 1997-07-23
Granted: 2003-09-15
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 9-13 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 9-13 days, and a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 11-15 days beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 11-15 days, provided that the daily dosage of second phase progestin is greater than the daily dosage of the first phase progestin and that the daily dosage of the second phase estrogen is greater than or equal to the daily dosage of the first phase estrogen.
Patent AT-E222636-T1 (AT)
Inventor: ARAMBURU LUIS ANGEL RUANO
IPC: E05B47/00
Filed: 1998-02-27
Granted: 2002-09-15
Abstract: The safety lock includes respective outer (1) and internal units (2) on both sides of a door (3) for the activation of a lock (4) which comprises a main bolt (4a) and a safety bolt (4b). The outer unit comprises an armoured casing (5) with a first reed (6), carrying the outer door handle (7), and a second reed (8), carrying a rectangular shaft (9) which operates the main bolt. A bolt (10) which can be pressed down, couples the first reed and the second reed, and a holder (11) is permanently connected with the bolt. A rocker arm (12) with an elastic arm drives the holder and is driven in opposed directions through a motor-driven activation arrangement (13) and through an emergency lever (14). An electronic card reader (15) activates the activation arrangement, and an emergency lock cylinder (17) driven the emergency lever.
Patent AT-E215522-T1 (AT)
Inventor: KIEL WOLFGANG DR
IPC: B01J23/44
Filed: 1998-06-17
Granted: 2002-04-15
Abstract: Preparation of cyclohexanones of formula (I) comprises hydrogenating phenols of formula (II) in presence of a palladium-on-carbon catalyst at 100-250 degrees C and a hydrogen pressure of 1-20 bars. The catalyst is added as a pre-mix with a base component (III) and 20-200 wt.% (based on (III)) of water. R1-R5 = H, OH, 1-10C alkyl, 3-6C cycloalkyl, Ar, CH2Ar, OAr, 1-10C alkoxy, 3-8C cycloalkoxy, mono- or di-(1-4C alkyl)-amino, 1-4C acylamino, COOR6 or CH2R7; Ar = 6-10C aryl; R6 = H or 1-4C alkyl; and R7 = OH, 1-4C alkoxy or mono- or di-(1-4C alkyl)-amino.
Patent AT-E200458-T1 (AT)
Inventor: PEUKER MARC
IPC: A61J3/00
Filed: 1998-08-05
Granted: 2001-04-15
Abstract: The device has a partition between a chamber (14) containing the substance and a pocket (16) holding the application tool (13). The partition has an access area which can be selectively opened. The chamber is formed of flexible films, and the partition between the chamber and pocket is formed by opposite sided adhesion of the films. The access area is formed as an intended separation point (22) in the opposite sided connection of the two films.
Patent AT-E228655-T1 (AT)
Inventor: ARTER THOMAS
IPC: G01N31/22
Filed: 1998-05-05
Granted: 2002-12-15
Abstract: A dry analytical element is disclosed which can be used to sensitively and rapidly detect and quantitate protein. The assays are carried out using a dye that reacts with protein and molybdate ion to produce a measurable change in the spectral absorption of the dye. Also disclosed are polymers which stabilize and enhance the accuracy of the assay based on acrylamide, and compounds which reduce interference by bicarbonate.
Patent AT-E208023-T1 (AT)
Inventor: FISCHER HANS
IPC: F21V21/02
Filed: 1998-01-08
Granted: 2001-11-15
Abstract: PCT No. PCT/DE98/00044 Sec. 371 Date Jul. 12, 1999 Sec. 102(e) Date Jul. 12, 1999 PCT Filed Jan. 8, 1998 PCT Pub. No. WO98/30836 PCT Pub. Date Jul. 16, 1998A ceiling socket for ceiling lights includes a socket 25 and of a support piece 5, which is accommodated therein and has electrical clamping contacts. The support piece 5 is assigned a pivotably articulated suspension hook 6 which, in its use position, is folded out, pointing away from the ceiling, and, in its non-use position, is arranged with its suspension portion 14 parallel to the surface of the support piece 5. The suspension hook 6 has an anchoring piece 7 which is displaceably mounted in a guide 26 assigned to a fastening piece 27. In its non-use position, the anchoring piece 7 of the suspension hook 6 is arranged eccentrically in relation to the suspension position, which is arranged substantially centrically relative to the ceiling socket 1.
Patent AT-E202180-T1 (AT)
Inventor: SCHWOERER ARTUR
IPC: E04G5/08
Filed: 1998-03-18
Granted: 2001-06-15
Abstract: The invention relates to a dismountable scaffolding with vertical struts and horizontal struts. A base plate extends between said struts and is provided with hook-shaped end fittings on each front face. Said base plate can be placed on a rail section in such a way that vertical locking or unlocking can be selectably achieved by sliding the end fitting in the direction of the rail section. Horizontal antislip locking is achieved and cancelled by raising the end fitting, thereby preventing said fitting from sliding into an inactive vertical locking position when it is in an active vertical position.
Patent AT-E249438-T1 (AT)
Inventor: SCHOU CHARLOTTE
IPC: C07D213/74
Filed: 1998-05-15
Granted: 2003-09-15
Abstract: The present invention relates to hitherto unknown compounds of formula (I) or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which formula R1 stands for one or more substituents which can be the same or different and are selected from the group consisting of: hydrogen, halogen, trifluoromethyl, carboxy, C1-C4 alkyl, alkoxy or alkoxycarbonyl, nitro, amino or cyano and Q stands for C4-C20 divalent hydrocarbon radical which can be straight, branched, cyclic, saturated or unsaturated and X stands for carbonyl, carbonylamino, aminocarbonyl, oxycarbonyloxy, oxycarbonyl, carbonyloxy, aminocarbonyloxy, aminothiocarbonyloxy, oxycarbonylamino or oxythiocarbonylamino and Y stands for benzylene or phenylene and R2 stands for one or more substituents which can be the same or different and are selected from the group consisting of: hydrogen, C1-C4 alkyl, hydroxyalkyl or alkoxy, hydroxy, halogen, trifluoromethyl, cyano, carboxamido, sulfamoyl, nitro, amino, carboxy, alkoxycarbonyl or benzyloxy; and pharmaceutically acceptable, non-toxic salts and N-oxides thereof. The present compounds are of value in the human and veterinary practice.
Patent AT-E210921-T1 (AT)
Inventor: VELINGS NICOLAS
IPC: A01N37/02
Filed: 1998-08-05
Granted: 2002-01-15
Abstract: A disinfecting composition which is bactericidal and effective to kill yeast includes (a) at least one a monocarboxylic acid of formula R-COOH, in which R a saturated or unsaturated, straight- or branched-chain alkyl radical comprising from 6 to 12 carbon atoms; (b) a strong inorganic acid; (c) at least one organic acid of formula R'CH2-CO2H, in which R' is H or OH; (d) at least one anionic surfactant; (e) at least one solubilizing agent consisting of a compound of formula R''O(CH2CH2O)x-H, in which R'' represents a C2 to C6 alkyl radical, x represents an integer from 1 to 3; and (f) water.
Patent AT-E239172-T1 (AT)
Inventor: TREMOULET OLIVIER L JR
IPC: F04B53/16
Filed: 1998-09-17
Granted: 2003-05-15
Abstract: A method and apparatus for biasing a seal assembly in a high pressure fluid pump. In one embodiment, the fluid pump includes a reciprocating plunger, a seal carrier disposed about the plunger, and a seal supported by the seal carrier and sealably engaged with the plunger. The seal may be biased toward the seal carrier with a spring and may include a flange that engages the spring to restrict lateral motion of a spring relative to the reciprocating plunger. The flange may engage an inner and/or an outer surface of the spring. Where the spring is a coil spring, the flange may be continuous around the circumference of the spring or may include a plurality of spaced apart projections located around the circumference of the spring.
Patent AT-E360433-T1 (AT)
Inventor: MATSUZAWA YUJI
IPC: A61K38/00
Filed: 1998-10-27
Granted: 2007-05-15
Abstract: The invention provides not only a smooth muscle growth inhibitory composition and a composition for inhibiting expression of adhesion molecules in vascular endothelial cells, each comprising the adipose tissue-specific secretory factor apM1 as an active ingredient, but also a method for diagnosis of arteriosclerosis which comprises assaying apM1 in a sample, an antibody against apM1, and a diagnostic kit for arteriosclerosis which comprises the antibody as an active component, all of which contribute to the elucidation of obesity-related genes and corresponding expression products which are useful for the etiologic exploration and establishment of therapeutic modalities for various obesity-related diseases, particularly arteriosclerosis inclusive of angina pectoris and myocardial infarction. By utilizing the information thus obtained, therapeutic and diagnostic methods for various diseases can be established.
Patent AT-E233436-T1 (AT)
Inventor: LEUSCHNER RAINER
IPC: C04B35/52
Filed: 1998-11-18
Granted: 2003-03-15
Abstract: A thin, flat, and porous carbon gas diffusion electrode having a side in contact with a supply of gas and a side in contact with an electrolyte, comprises a pyrolysis product of a composite of an organic aerogel or xerogel and a reinforcing skeleton consisting at least in part of organic material. The porosity of the carbon gas diffusion electrode according to the invention can be regulated at will while the surface of the electrode is smooth.
Patent AT-E212687-T1 (AT)
Inventor: HAYAKAWA YOSHIYUKI
IPC: E04G9/00
Filed: 1999-02-25
Granted: 2002-02-15
Abstract: A form member (20) comprises a strip-shaped main plate portion (21), which is flat at least on its front surface, a horizontal pair of strip-shaped side plate portions (22a, 22b) extending from both sides of the main plate portion (21) toward its rear surface perpendicularly to the main plate portion (21), and a reinforcing plate (23a, 23b) provided to extend from the rear surface of the main plate portion (21) substantially in parallel with the horizontal pair of side plate portions (22a, 22b). Each of the side plate portions (22a, 22b) and the reinforcing plate (23a, 23b) includes an enlarged end portion (25a, 25b, 26a, 26b) over a prescribed width from its opening end. An end plate body (30) having an engaging portion (32) of a shape for tightly engaging with an end of the form member body (20) engages with this end, to form a single form member. A concrete form member reduced in thickness and weight and enabled to suppress inconvenient deformation in concrete placing can be provided due to this structure. <IMAGE>
Patent AT-E259699-T1 (AT)
Inventor: GREISEL FRANZ XAVER
IPC: B28B1/50
Filed: 1999-04-22
Granted: 2004-03-15
Abstract: The sieve unit (14) is cleaned by means of water from concrete residues at least after a few mold filling operations. The claimed apparatus is characterized by the presence of means (20,22) for cleaning the sieve unit.
Patent AT-E256833-T1 (AT)
Inventor: MUELLER FRITZ
IPC: F16K37/00
Filed: 1999-05-28
Granted: 2004-01-15
Abstract: The arrangement has a linear potentiometer (12) coupled to the valve, which generates an analogue, proportional signal. The signal is fed to a microprocessor (14) with one or more relays (16,18) connected to its output
Patent AT-E221060-T1 (AT)
Inventor: MAYWALD VOLKER DR
IPC: C07D407/04
Filed: 1999-09-02
Granted: 2002-08-15
Abstract: Separation of impurities from 3-(2'-acetoxyethyl)-dihydro-2(3H)-furanone (I) obtained by acetylation of 3-(2'-hydroxyethyl)-dihydro-2(3H)-furanone comprises first separating high boiling impurities and subjecting the recovered distillation head product to a further step in which light and medium boiling components are taken off at the head and recovering pure (I) as the sump product.
Patent AT-E278515-T1 (AT)
Inventor: ERBEN MARCUS DIPL ING
IPC: B23Q1/56
Filed: 1999-10-13
Granted: 2004-10-15
Abstract: The arrangement has a carrier (29) on which the final working element is mounted with at least two linear actuators (13) pivotably mounted on the carrier with different pivot axes and linked to the final working element (15) at different points A further drive moves the final working element and guides (20) for positive movement of the final working element in a pre-defined movement surface.
Patent AT-E202348-T1 (AT)
Inventor: BAUDRY RICHARD
IPC: A61K8/00
Filed: 1999-08-25
Granted: 2001-07-15
Abstract: Quinoline or quinoxaline 5,8-diones (I) and 5,8-diols (II) are used to dye keratinic fibers. Compounds of formula (I) and (II) are used to dye keratinic fibers. Q = a group of formula (i)-(iv); X = CH or N; T = H, halogen or OH; R1-R5 = H, 1-4C alkoxy, NW1W2, NHCOW1, OCOW1, OH, COOH (optionally derivatized), halogen, or 1-4C alkyl optionally substituted by CN, COOH (optionally derivatized), OH, OCOW1, tosyloxy, COOW1, OSi(W1)3, NW1W2, NHCOMe or CONW1W2; Z = H; benzyl; phenyl optionally substituted by OH, OCOW1, NW1W2, NHCOW1 or CN; 1-8C alkyl optionally substituted by CN, COOH (optionally derivatized), OH, OCOW1, tosyloxy, COOW1, OSi(W1)3, NW1W2, NHCOMe or CONW1W2; W1, W2 = H or 1-4C alkyl; and W3, W4 = H or 1-4C alkyl optionally substituted by OH, COOW1, OCOW1 or NW1W2. Independent claims are also included for the following: (1) compounds of formula (I) and (II) with the proviso that: (a) Z is not methyl when Q is (ii), X is CH and T is H; and (b) NW3W4 is not methylamino, n-butylamino, dimethylamino or diethylamino when Q is (i); (2) a composition for dyeing keratinic fibers, containing at least one compound (I) or (II); and (3) a method for direct dyeing of keratinic fibers, comprising applying a composition containing at least one compound (I) or (II), allowing time for the desired color to develop, and rinsing, optionally washing, re-rinsing and drying the fibers.
Patent AT-E257296-T1 (AT)
Inventor: RAPP LUTZ
IPC: H04B10/07
Filed: 1999-02-09
Granted: 2004-01-15
Abstract: The method involves branching (11,14) test sub-beams (S0-S2) from the carrier beam without causing distortion; treating the sub-beams by subjecting a first one to abnormal dispersion and subjecting at least a second and/or third sub-beam to normal or no dispersion; pulsed sampling of the dispersed sub-beams to obtain electrical intensity values (I0-I2) ; and computing test parameters from the intensity values as a quantitative measure of the transmitted signal quality. Independent claims are also included for : (1) an arrangement for testing the quality of an optical transmission signal; (2) and for an application of the method and/or system.
Patent AT-E272995-T1 (AT)
Inventor: HOEFFKES HORST
IPC: A61Q5/04
Filed: 1999-03-04
Granted: 2004-08-15
Abstract: The invention relates to a novel method for simultaneously perming and dyeing hair. Before and/or after being mechanically deformed, the hair is treated with a keratin reduction agent, rinsed and set with an oxidation agent. An aqueous preparation containing a mercapto compound or a sulphite and at least one reactive carbonyl compound-type dye chosen from the group of aromatic, heteroaromatic or unsaturated aldehydes or ketones, the dialdehydes or diketones or their acetals, hemiaminals or imine derivatives is used for reducing keratin. The preparation preferably also contains a compound with a primary or secondary amino- or hydroxy group chosen from amino acids, peptides, aromatic amines, phenols, aminophenols or nitrogen-containing heterocycles, in order to intensify the colour.
Patent AT-E369420-T1 (AT)
Inventor: KEATING MARK T
IPC: A01K67/027
Filed: 1999-05-12
Granted: 2007-08-15
Abstract: The genomic structure including the sequence of the intron/exon junctions is disclosed for KVLQT1 and KCNE1 which are genes associated with long QT syndrome. Additional sequence data for the two genes ARE also disclosed. Also disclosed are newly found mutations in KVLQT1 which result in long QT syndrome. The intron/exon junction sequence data allow for the design of primer pairs to amplify and sequence across all of the exons of the two genes. This can be used to screen persons for the presence of mutations which cause long QT syndrome. Assays can be performed to screen persons for the presence of mutations in either the DNA or proteins. The DNA and proteins may also be used in assays to screen for drugs which will be useful in treating or preventing the occurrence of long QT syndrome.
Patent AT-E263572-T1 (AT)
Inventor: CHOWERS MICHAEL Y
IPC: A61K45/00
Filed: 1999-06-17
Granted: 2004-04-15
Abstract: The invention relates to pharmaceutical compositions and methods for treating and/or preventing Helicobacter pylori-associated disorders, particularly disorders of the gastrointestinal tract. The pharmaceutical compositions comprise as active ingredient a therapeutically effective amount of a compound which inhibits the growth-enhancing effect of gastrin on H. pylori. The active ingredient may specifically be a compound which is capable of inhibiting gastrin uptake by H. pylori, and/or which is an antagonist of the human or H. pylori gastrin receptor.
Patent AT-E263489-T1 (AT)
Inventor: RUBIO SUSAN VICTOR
Filed: 1999-07-23
Granted: 2004-04-15
Abstract: Protection of plants against pathogenic fungi is achieved by the use of binucleate Rhizoctonia selected through the molecular detection of certain ITS ribosomal sequences, the protective strains suitably being members of a phylogenetically differentiated cluster. A new group of binucleate Rhizoctonia is thereby provided. ITS data, especially the ITS1 data, is employed to distinguish suitable isolates.
Patent AT-E317840-T1 (AT)
Inventor: COOK JOHN
IPC: B01J23/68
Filed: 1999-09-01
Granted: 2006-03-15
Abstract: A process for the production of acetic acid, which process comprises contacting ethane and/or ethylene with a molecular oxygen-containing gas in a fluid bed reactor in the presence of a microspheroidal fluidised particulate solid oxidation catalyst, wherein at least 90% of said catalyst particles are less than 300 microns.